Newfound physiological function of FAIM protein offers hope of novel disease-modifying therapy for Alzheimer's disease

被引：1
|
作者：
Balaj, Allison R. [1 ]
Kaku, Hiroaki [1 ]
机构：
[1] Western Michigan Univ, Homer Stryker MD Sch Med, Dept Invest Med, Kalamazoo, MI 49008 USA
来源：
NEURAL REGENERATION RESEARCH | 2023年 / 18卷 / 12期
关键词：
INHIBITORY MOLECULE FAIM; B-CELLS; EXPRESSION;
D O I：
10.4103/1673-5374.374003
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：2677 / 2679
页数：3
相关论文
共 50 条
  • [21] Disease-modifying treatment approaches for Alzheimer's disease
    Froelich, Lutz
    Hausner, Lucrezia
    NERVENARZT, 2021, 92 (12): : 1239 - 1248
  • [22] Possible Consequences of the Approval of a Disease-Modifying Therapy for Alzheimer Disease
    Musiek, Erik S.
    Morris, John C.
    JAMA NEUROLOGY, 2021, 78 (02) : 141 - 142
  • [23] Alzheimer disease: From basic study to disease-modifying therapy
    Iwatsubo, Takeshi
    NEUROSCIENCE RESEARCH, 2009, 65 : S4 - S4
  • [24] An Interprofessional Team for Disease-Modifying Therapy in Alzheimer Disease Implementation
    Turk, Katherine W.
    Knobel, Mark D.
    Nothern, Alexandra
    Friedman, Garrett
    Noah, Hannah
    Campbell, Brendan
    Anderson, Diana C.
    Charidimou, Andreas
    Mills, Andrew
    Coronel, Vanessa
    Pierre, Nacha
    Reynolds, Beverly V.
    Wagner, Caroline
    Varga, Leanne M.
    Roefaro, John
    Triantafylidis, Laura
    Budson, Andrew E.
    NEUROLOGY-CLINICAL PRACTICE, 2024, 14 (06)
  • [25] M1 Agonists as a Potential Disease-Modifying Therapy for Alzheimer's Disease
    Caccamo, Antonella
    Fisher, Abraham
    LaFerla, Frank M.
    CURRENT ALZHEIMER RESEARCH, 2009, 6 (02) : 112 - 117
  • [26] Alzheimer's disease: Have we opened the Golden Gate to disease-modifying therapy?
    Isaacs, Jeremy D.
    CEREBRAL CIRCULATION-COGNITION AND BEHAVIOR, 2024, 6
  • [27] Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease
    Gao, Xiaoya
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [28] Disease-modifying treatment for Alzheimer's disease: the neurotrophic approach
    Bossi, L
    ALZHEIMERS REPORTS, 1998, 1 : S29 - S30
  • [29] Huperzine A: is it an effective disease-modifying drug for Alzheimer's disease?
    Qian, Zhong Ming
    Ke, Ya
    FRONTIERS IN AGING NEUROSCIENCE, 2014, 6
  • [30] Development of disease-modifying therapies against Alzheimer's disease
    Iwatsubo, Takeshi
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2024, 78 (09) : 491 - 494
12345